AC Health brings ‘Care Beyond Cure’ to Healthway QualiMed Hospital Iloilo and launches first fertility and reproductive health hub in Western Visayas
ILOILO – On May 22, 2023, Ayala Healthcare Holdings Inc. (AC Health) officially unveiled QualiMed Iloilo’s new name and signage – Healthway QualiMed Hospital Iloilo. This comes after the rebranding launches of the Healthway QualiMed Hospital Santa Rosa and Healthway QualiMed Hospital San Jose del Monte. The series of signage unveilings marks the integration of all AC Health’s hospitals and clinics under the Healthway Medical Network (HMN) brand.
Healthway QualiMed Hospital Iloilo unveils its new sign as part of Healthway Medical Network
On the same day, Healthway also launched its Women’s Center, with its flagship facility – the Iloilo Fertility and Reproductive Care Center (IFER). Women’s Health is one of the priority programs under Healthway’s Connected Care Circles, which offer a unique model of integrated multi-disciplinary team care based on global best practices. The Healthway Women’s Health program was developed with the support of I.E. Medica, a major importer of pharmaceutical products also within the AC Health portfolio. Through the program, Healthway addresses all aspects of a woman’s health - screening, diagnostics, and treatment.
The first of its kind in Western Visayas, IFER serves as the hub for fertility and reproductive needs of women and families. It is a one-stop shop, offering advanced diagnostics and interventions, including intrauterine insemination, in-vitro fertilization fertility banking.
From L-R: Healthway QualiMed Hospital Iloilo Medical Director Dr. James Woo, Healthway QualiMed Hospital Iloilo Chief Operations Officer Joseph Ladrido, Iloilo Fertility and Reproductive Care Center Head Dr. Rey Castillo, Panay Medical Ventures, Inc. Board of Director Dr. Henry Tupas, Ayala Corporation Business Development and Digital Ventures Head Jaime Alfonso Zobel de Ayala, AC Health President and Chief Executive Officer Paolo Borromeo, Iloilo Governor Arthur Defensor Jr., Iloilo City Local Economic and Investment Promotions Office Head Francis Cruz, ACEN Corporation Vice President of Business Development Jaime Z. Urquijo, and QualiMed Health Network Group Chief Operations Officer Margaret Bengzon
“Women’s Health is integral to our vision of Connected Care Circles. Through all of our Women’s Health Centers across our Healthway Medical network, we are able to provide seamless, coordinated, and cost-effective care in response to the complex and unique health needs of women,” said Paolo Borromeo, President and CEO of AC Health.
“'Care Beyond Cure,” HMN’s brand promise, conveys its innovative model of care,” Margaret Bengzon, Healthway QualiMed Group COO, explained. “Today, as we launch our Healthway Medical Network brand, we reaffirm our commitment to human-centric care – integrated care that leverages the entire HMN network in responding to the full range of our patient’s needs.”
From L-R: ACEN Corporation Vice President of Business Development Jaime Z. Urquijo, AC Health President and Chief Executive Officer Paolo Borromeo, Iloilo Governor Arthur Defensor Jr., Healthway QualiMed Hospital Iloilo Chief Operations Officer Joseph Ladrido, QualiMed Health Network Group Chief Operations Officer Margaret Bengzon, and Ayala Corporation Business Development and Digital Ventures Head Jaime Alfonso Zobel de Ayala
Also present during the event were key executives from Ayala Corporation, AC Health, and HMN, as well as local government officials from Iloilo, representatives from various sectors of the community, and physicians, staff, and existing patrons of Healthway QualiMed Iloilo. In attendance were Jaime Alfonso Zobel de Ayala, Head, Business Development and Digital Ventures of Ayala Corporation; and Jaime Z. Urquijo, Vice President, Business Development of ACEN Corporation.
Throughout the year, HMN also plans to open three more multispecialty centers in Cebu, Cagayan de Oro, and Davao, expanding the Healthway Medical Network to a total of 15 outpatient centers by the end of 2023.